Phenolic phytochemicals and bone

Phytochemistry Reviews

Volumn 7, Issue 2, 2008, Pages 313-344

  Habauzit, Véronique ^a   Horcajada, Marie Noëlle ^a  

^a INRA and University of Auvergne   (France)

Author keywords

Bone metabolism; Flavonoids; Osteoporosis; Phenolics; Phytonutrients

Indexed keywords

8 PRENYLNARINGENIN; ANTHOCYANIN; BLACK LUCQUES OLIVE OIL; CHLOROGENIC ACID; COUMARIN; DAIDZEIN; ELLAGITANNIN; ESSENTIAL OIL; FLAVANOL DERIVATIVE; FLAVANONE; FLAVONOL; GENISTEIN; GREEN LUCQUES OLIVE OIL; HESPERIDIN; ISOFLAVONE; ISOFLAVONOID; ISOPENTENYLNARINGENIN; LIGNAN; NARINGENIN; OLEUROPEIN; OLIVE OIL; PINE OIL; PROANTHOCYANIDIN; RESVERATROL; SECOISOLARICIRESINOL; SOYBEAN PROTEIN; TANNIN; THEAFLAVIN; THYME OIL; UNINDEXED DRUG;

BIOLOGICAL ACTIVITY; BONE; BONE CELL; BONE DENSITY; BONE MASS; BONE METABOLISM; BONE REMODELING; BONE STRUCTURE; CALCIUM INTAKE; CHRONIC DISEASE; DIET; FRACTURE; FRUIT; HUMAN; MACRONUTRIENT; NONHUMAN; OSSIFICATION; OSTEOLYSIS; OVARIECTOMY; PHYTOCHEMISTRY; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RED WINE; REVIEW; SOYBEAN; THYME; VEGETABLE; VITAMIN INTAKE;

ANIMALIA;

EID: 43049181555     PISSN: 15687767     EISSN: 1572980X     Source Type: Journal    
DOI: 10.1007/s11101-007-9078-9     Document Type: Review

References (198)

1. Alekel DL, Germain AS, Peterson CT et al (2000) Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr 72(3):844-852
2. Anderson GL, Limacher M, Assaf AR et al (2004) Effects of conjugated, equine estrogen in postmenopausal women with hysterectomy - The women's health initiative randomized controlled trial. Jama 291(14):1701-1712
3. Anderson JJ, Ambrose WW, Garner SC (1998) Biphasic effects of genistein on bone tissue in the ovariectomized, lactating rat model. Proc Soc Exp Biol Med 217(3):345-350
4. Arjmandi BH, Alekel L, Hollis BW et al (1996) Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 126(1):161-167
5. Arjmandi BH, Birnbaum R, Goyal NV et al (1998a) Bone-sparing effect of soy protein in ovarian hormone-deficient rats is related to its isoflavone content. Am J Clin Nutr 68(6 Suppl):1364S-1368S
6. Arjmandi BH, Getlinger MJ, Goyal NV et al (1998b) Role of soy protein with normal or reduced isoflavone content in reversing bone loss induced by ovarian hormone deficiency in rats. Am J Clin Nutr 68(6 Suppl):1358-1363
7. Arjmandi BH, Khalil DA, Lucas EA et al (2002) Dried plums improve indices of bone formation in postmenopausal women. J Wom Health Gend Base Med 11(1):61-68
8. Arjmandi BH, Khalil DA, Smith BJ et al (2003) Soy protein has a greater effect on bone in postmenopausal women not on hormone replacement therapy, as evidenced by reducing bone resorption and urinary calcium excretion. J Clin Endocrinol Metab 88(3):1048-1054
9. Arjmandi BH, Lucas EA, Khalil DA et al (2005) One year soy protein supplementation has positive effects on bone formation markers but not bone density in postmenopausal women. Nutr J 4:8
10. Arts IC, van de Putte B, Hollman PC (2000a) Catechin contents of foods commonly consumed in The Netherlands. 1. Fruits, vegetables, staple foods, and processed foods. J Agric Food Chem 48(5):1746-1751
11. Arts IC, van de Putte B, Hollman PC (2000b) Catechin contents of foods commonly consumed in The Netherlands. 2. Tea, wine, fruit juices, and chocolate milk. J Agric Food Chem 48(5):1752-1757
12. Atkinson C, Compston JE, Day NE et al (2004) The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 79(2):326-333
13. Aziz MH, Kumar R, Ahmad N (2003) Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review). Int J Oncol 23(1):17-28
14. Bahr JM, Nakai M, Rivera A et al (2005) Dietary soy protein and isoflavones: minimal beneficial effects on bone and no effect on the reproductive tract of sexually mature ovariectomized Sprague-Dawley rats. Menopause 12(2):165-173
15. Bandyopadhyay S, Lion JM, Mentaverri R et al (2006) Attenuation of osteoclastogenesis and osteoclast function by apigenin. Biochem Pharmacol 72(2):184-197
16. Baron R (2001) L'ostéoclaste et les mécanismes moléculaires de la résorption osseuse. MS Med Sci 17:1260-1269
17. Baylink DJ, Finkelman RD, Mohan S (1993) Growth factors to stimulate bone formation. J Bone Miner Res 8 Suppl 2:S565-572
18. Blair HC, Jordan SE, Peterson TG et al (1996) Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats. J Cell Biochem 61(4):629-637
19. Boissy P, Andersen TL, Abdallah BM et al (2005) Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation. Cancer Res 65(21):9943-9952
20. Bok SH, Lee SH, Park YB et al (1999) Plasma and hepatic cholesterol and hepatic activities of 3-hydroxy-3-methyl-glutaryl-CoA reductase and acyl CoA: cholesterol transferase are lower in rats fed citrus peel extract or a mixture of citrus bioflavonoids. J Nutr 129(6):1182-1185
21. Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423:337-342
22. Bradamante S, Barenghi L, Villa A (2004) Cardiovascular protective effects of resveratrol. Cardiovasc Drug Rev 22(3):169-188
23. Breitman PL, Fonseca D, Cheung AM et al (2003) Isoflavones with supplemental calcium provide greater protection against the loss of bone mass and strength after ovariectomy compared to isoflavones alone. Bone 33(4):597-605
24. Bringhurst FR, Demay MB, Krane SM et al (2005) Bone and mineral metabolism in health and disease. In: Kasper DL, Braunwald E, Fauci ASet al (eds) Harrison's principles of internal medicine. Mc Graw-Hill, New York, pp 2238-2249
25. Bu S, Lucas E, Franklin M et al (2007) Comparison of dried plum supplementation and intermittent PTH in restoring bone in osteopenic orchidectomized rats. Osteoporos Int 18(7):931-942
26. Calliste CA, Le Bail JC, Trouillas P et al (2001) Chalcones: Structural requirements for antioxidant, estrogenic and antiproliferative activities. Anticancer Res 21(6A):3949-3956
27. Cassidy A, Dalais FS (2003) Phytochemicals. In: Gibney MJ, Macdonald IA, Roche HM (eds) Nutrition and metabolism. Blackwell Publishing, Oxford, pp 307-317
28. Chang H, Jin TY, Jin WF et al (2003) Modulation of isoflavones on bone-nodule formation in rat calvaria osteoblasts in vitro. Biomed Environ Sci 16(1):83-89
29. Chang JK, Hsu YL, Teng IC et al (2006) Piceatannol stimulates osteoblast differentiation that may be mediated by increased bone morphogenetic protein-2 production. Eur J Pharmacol 551(1-3):1-9
30. Chen CH, Ho ML, Chang JK et al (2005) Green tea catechin enhances osteogenesis in a bone marrow mesenchymal stem cell line. Osteoporos Int 16(12):2039-2045
31. Chiba H, Uehara M, Wu J et al (2003) Hesperidin, a citrus flavonoid, inhibits bone loss and decreases serum and hepatic lipids in ovariectomized mice. J Nutr 133(6):1892-1897
32. Chiechi LM, Secreto G, D'Amore M et al (2002) Efficacy of a soy rich diet in preventing postmenopausal osteoporosis: the Menfis randomized trial. Maturitas 42(4):295-300
33. Choi EM, Hwang JK (2003) Effects of (+)-catechin on the function of osteoblastic cells. Biol Pharm Bull 26(4):523-526
34. Clarke DB, Lloyd AS, Botting NP et al (2002) Measurement of intact sulfate and glucuronide phytoestrogen conjugates in human urine using isotope dilution liquid chromatography-tandem mass spectrometry with [13C(3)]isoflavone internal standards. Anal Biochem 309(1):158-172
35. Clifford MN (1999) Chlorogenic acids and other cinnamates - nature, occurrence and dietary burden. J Sci Food Agr 79(3):362-372
36. Clifford MN, Brown JE (2006) Dietary flavonoids and health - broadening the perspective. In: Andersen OM, Markham KR (eds) Flavonoids: chemistry, biochemistry and applications. CRC Press, Boca Raton, pp 319-370
37. Clifford MN, Scalbert A (2000) Ellagitannins - nature, occurrence and dietary burden. J Sci Food Agr 80(7):1118-1125
38. Consensus development conference (1993) Diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 94(6):646-650
39. Cooper C, Campion G, Melton LJ 3rd (1992) Hip fractures in the elderly: a world-wide projection. Osteoporos Int 2(6):285-289
40. Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359(9319):1761-1767
41. Day AJ, Mellon F, Barron D et al (2001) Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin. Free Radic Res 35(6):941-952
42. de la Puerta R, Ruiz Gutierrez V, Hoult JR (1999) Inhibition of leukocyte 5-lipoxygenase by phenolics from virgin olive oil. Biochem Pharmacol 57(4):445-449
43. De Vernejoul MC, Marie PJ (1993) Cellules osseuses et remodelage osseux. MS Med Sci 9(11):1192-1203
44. De Wilde A, Colin C, Lacroix A (2001) In vivo and ex vivo effects of an isoflavone-rich diet on bone formation in growing pigs. Ann Nutr Metab 45:227(abstr)
45. De Wilde A, Lieberherr M, Colin C et al (2004) A low dose of daidzein acts as an ERbeta-selective agonist in trabecular osteoblasts of young female piglets. J Cell Physiol 200(2):253-262
46. Delaisse JM, Eeckhout Y, Vaes G (1986) Inhibition of bone resorption in culture by (+)-catechin. Biochem Pharmacol 35(18):3091-3094
47. Deyhim F, Garica K, Lopez E et al (2006) Citrus juice modulates bone strength in male senescent rat model of osteoporosis. Nutrition 22(5):559-563
48. Deyhim F, Stoecker BJ, Brusewitz GH et al (2005) Dried plum reverses bone loss in an osteopenic rat model of osteoporosis. Menopause 12(6):755-762
49. Dodin S, Lemay A, Jacques H et al (2005) The effects of flaxseed dietary supplement on lipid profile, bone mineral density, and symptoms in menopausal women: a randomized, double-blind, wheat germ placebo-controlled clinical trial. J Clin Endocrinol Metab 90(3):1390-1397
50. Ducy P (2000) Cbfa1: a molecular switch in osteoblast biology. Dev Dyn 219(4):461-471
51. Effenberger KE, Johnsen SA, Monroe DG et al (2005) Regulation of osteoblastic phenotype and gene expression by hop-derived phytoestrogens. J Steroid Biochem Mol Biol 96(5):387-399
52. Erlund I, Meririnne E, Alfthan G et al (2001) Plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice. J Nutr 131(2):235-241
53. Fang N, Yu S, Prior RL (2002) LC/MS/MS characterization of phenolic constituents in dried plums. J Agric Food Chem 50(12):3579-3585
54. Fanti P, Monier-Faugere MC, Geng Z et al (1998) The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats. Osteoporos Int 8(3):274-281
55. Ferry DR, Smith A, Malkhandi J et al (1996) Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin Cancer Res 2(4):659-668
56. Fonseca D, Ward WE (2004) Daidzein together with high calcium preserve bone mass and biomechanical strength at multiple sites in ovariectomized mice. Bone 35(2):489-497
57. Formica JV, Regelson W (1995) Review of the biology of Quercetin and related bioflavonoids. Food Chem Toxicol 33(12):1061-1080
58. Franceschi RT, Xiao GZ (2003) Regulation of the osteoblast-specific transcription factor, runx2: Responsiveness to multiple signal transduction pathways. J Cell Biochem 88(3):446-454
59. Franklin M, Bu SY, Lerner MR et al (2006) Dried plum prevents bone loss in a male osteoporosis model via IGF-I and the RANK pathway. Bone 39(6):1331-1342
60. Gao YH, Yamaguchi M (1998) Zinc enhancement of genistein's anabolic effect on bone components in elderly female rats. Gen Pharmacol 31(2):199-202
61. Gao YH, Yamaguchi M (1999a) Anabolic effect of daidzein on cortical bone in tissue culture: comparison with genistein effect. Mol Cell Biochem 194(1-2):93-97
62. Gao YH, Yamaguchi M (1999b) Suppressive effect of genistein on rat bone osteoclasts: apoptosis is induced through Ca2+ signaling. Biol Pharm Bull 22(8):805-809
63. Gao YH, Yamaguchi M (2000) Suppressive effect of genistein on rat bone osteoclasts: involvement of protein kinase inhibition and protein tyrosine phosphatase activation. Int J Mol Med 5(3):261-267
64. Garg A, Garg S, Zaneveld LJ et al (2001) Chemistry and pharmacology of the Citrus bioflavonoid hesperidin. Phytother Res 15(8):655-669
65. Ge YB, Chen DW, Xie LP et al (2006) Enhancing effect of daidzein on the differentiation and mineralization in mouse osteoblast-like MC3T3-E1 cells. Yakugaku Zasshi-J Pharmaceut Soc Jpn 126(8):651-656
66. Greendale GA, FitzGerald G, Huang MH et al (2002) Dietary soy isoflavones and bone mineral density: results from the study of women's health across the nation. Am J Epidemiol 155(8):746-754
67. Gu LW, Kelm MA, Hammerstone JF et al (2004) Concentrations of proanthocyanidins in common foods and estimations of normal consumption. J Nutr 134(3):613-617
68. Gu X, Creasy L, Kester A et al (1999) Capillary electrophoretic determination of resveratrol in wines. J Agric Food Chem 47(8):3223-3227
69. Harrison E, Adjei A, Ameho C et al (1998) The effect of soybean protein on bone loss in a rat model of postmenopausal osteoporosis. J Nutr Sci Vitaminol (Tokyo) 44(2):257-268
70. Hayashi SI, Yamane T, Miyamoto A et al (1998) Commitment and differentiation of stem cells to the osteoclast lineage. Biochem Cell Biol 76(6):911-922
71. Heaney RP (2007) Bone health. Am J Clin Nutrition 85(1):300S-303S
72. Hegarty VM, May HM, Khaw KT (2000) Tea drinking and bone mineral density in older women. Am J Clin Nutr 71(4):1003-1007
73. Hertog MG, Hollman PC (1996) Potential health effects of the dietary flavonol quercetin. Eur J Clin Nutr 50(2):63-71
74. Hofbauer LC, Heufelder AE (2001) Role of receptor activator of nuclear factor-kappa B ligand and osteoprotegerin in bone cell biology. J Mol Med 79(5-6):243-253
75. Hollman PCH (2001) Evidence for health benefits of plant phenols: local or systemic effects? J Sci Food Agr 81(9):842-852
76. Hollman PCH, Arts ICW (2000) Flavonols, flavones and flavanols-nature, occurrence and dietary burden. J Sci Food Agr 80(7):1081-1093
77. Hollman PCH, Bijsman M, van Gameren Y et al (1999) The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man. Free Radic Res 31(6):569-573
78. Horcajada M, Coxam V (2004) Hesperidin, a citrus flavanone, improves bone acquisition and prevents skeletal impairment in rats. In: Burckardt P, Dawson-Hughes B, Heaney RP (eds) Nutritional aspects of osteoporosis, pp 103-120
79. Horcajada-Molteni MN, Crespy V, Coxam V et al (2000a) Rutin inhibits ovariectomy-induced osteopenia in rats. J Bone Mineral Res 15(11):2251-2258
80. Horcajada-Molteni MN, Davicco MJ, Lebecque P et al (2000b) Effect of lignans on ovariectomy-induced bone loss in rats. J Bone Miner Res 15(suppl):S553
81. Humpel M, Isaksson P, Schaefer O et al (2005) Tissue specificity of 8-prenylnaringenin: protection from ovariectomy induced bone loss with minimal trophic effects on the uterus. J Steroid Biochem Mol Biol 97(3):299-305
82. Ilich JZ, Kerstetter JE (2000) Nutrition in bone health revisited: a story beyond calcium. J Am Coll Nutr 19(6):715-737
83. Ishida H, Uesugi T, Hirai K et al (1998) Preventive effects of the plant isoflavones, daidzin and genistin, on bone loss in ovariectomized rats fed a calcium-deficient diet. Biol Pharm Bull 21(1):62-66
84. Ishida H, Uesugi T, Toda T et al (2000) Effects of Soy Isoflavones, Daidzein, Genistein and Glycitein, on Bone Loss and Lipid Metabolic Pathway in Ovariectomized Rats. J Nutr 130(3):680S
85. Ishikawa M, Maki K, Tofani I et al (2005) Grape seed proanthocyanidins extract promotes bone formation in rat's mandibular condyle. Eur J Oral Sci 113(1):47-52
86. Ishimi Y, Miyaura C, Ohmura M et al (1999) Selective effects of genistein, a soybean isoflavone, on B-lymphopoiesis and bone loss caused by estrogen deficiency. Endocrinology 140(4):1893-1900
87. Ishimi Y, Yoshida M, Wakimoto S et al (2002) Genistein, a soybean isoflavone, affects bone marrow lymphopoiesis and prevents bone loss in castrated male mice. Bone 31(1):180-185
88. Jayo MJ, Anthony MS, Register TC et al (1996) Dietary soy isoflavones and bone loss: a study in ovariectomized monkeys. J Bone Miner Res 11:228 (abstr)
89. Jeffery EH, Walsh J, Rivera A et al (2000) Soy isoflavones may enhance bone density in Ovariectomized rats. J Nutr 130(3):666S
90. Jia TL, Wang HZ, Xie LP et al (2003) Daidzein enhances osteoblast growth that may be mediated by increased bone morphogenetic protein (BMP) production. Biochem Pharmacol 65(5):709-715
91. Johnell O, Gullberg B, Kanis JA et al (1995) Risk factors for hip fracture in European women: the MEDOS Study. Mediterranean Osteoporosis study. J Bone Miner Res 10(11):1802-1815
92. Kamitani Y, Maki K, Tofani I et al (2004) Effects of grape seed proanthocyanidins extract on mandibles in developing rats. Oral Dis 10(1):27-31
93. Kanis J, Johnell O, Gullberg B et al (1999) Risk factors for hip fracture in men from southern Europe: the MEDOS study. Mediterranean Osteoporosis study. Osteoporos Int 9(1):45-54
94. Kanno S, Hirano S, Kayama F (2004) Effects of phytoestrogens and environmental estrogens on osteoblastic differentiation in MC3T3-E1 cells. Toxicology 196(1-2):137-145
95. Katagiri T, Takahashi N (2002) Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis 8(3):147-159
96. Khalil DA, Lucas EA, Smith BJ et al (2005) Soy isoflavones may protect against orchidectomy-induced bone loss in aged male rats. Calcif Tissue Int 76(1):56-62
97. Kim YJ, Bae YC, Suh KT et al (2006) Quercetin, a flavonoid, inhibits proliferation and increases osteogenic differentiation in human adipose stromal cells. Biochem Pharmacol 72(10):1268-1278
98. King RE, Bomser JA, Min DB (2006) Bioactivity of resveratrol. Compr Rev Food Sci Food Saf 5(3):65-70
99. Knekt P, Kumpulainen J, Jarvinen R et al (2002) Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 76(3):560-568
100. Kreijkamp-Kaspers S, Kok L, Grobbee DE et al (2004) Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial. JAMA 292(1):65-74
101. Kritz-Silverstein D, Goodman-Gruen DL (2002) Usual dietary isoflavone intake, bone mineral density, and bone metabolism in postmenopausal women. J Womens Health Gend Based Med 11(1):69-78
102. Kroon PA, Clifford MN, Crozier A et al (2004) How should we assess the effects of exposure to dietary polyphenols in vitro? Am J Clin Nutr 80(1):15-21
103. Kumpulainen JT (2001) Intake of flavonoids, phenolic acids and lignans in various populations. In: Voutilainen S, Salonen JT (eds) Proceedings of the 3rd international conference on natural antioxidants and anticarcinogens in food, health and disease, Kuopion University Publications D. Medical Sciences, Helsinki, p 24
104. Kurzer MS, Xu X (1997) Dietary phytoestrogens. Annu Rev Nutr 17:353-381
105. Lamson DW, Brignall MS (2000) Antioxidants and cancer, part 3: quercetin. Altern Med Rev 5:196-208
106. Liao S, Kao YH, Hiipakka RA (2001) Green tea: biochemical and biological basis for health benefits. Vitam Horm 62:1-94
107. Liu ZP, Li WX, Yu B et al (2005) Effects of trans-resveratrol from Polygonum cuspidatum on bone loss using the ovariectomized rat model. J Med Food 8(1):14-19
108. Lucas EA, Wild RD, Hammond LJ et al (2002) Flaxseed improves lipid profile without altering biomarkers of bone metabolism in postmenopausal women. J Clin Endocrinol Metab 87(4):1527-1532
109. Lydeking-Olsen E, Jensen JEB, Setchell KDR et al (2002) Isoflavone-rich soymilk prevents bone loss in the lumbar spine of postmenopausal women: a two-year study. J Nutr 132(3):581S-581S
110. Manach C, Morand C, Gil-Izquierdo A et al (2003) Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice. Eur J Clin Nutr 57(2):235-242
111. Manach C, Scalbert A, Morand C et al (2004) Polyphenols: food sources and bioavailability. Am J Clin Nutr 79(5):727-747
112. Manach C, Williamson G, Morand C et al (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81(1 Suppl):230S-242S
113. Manolagas SC (2000) Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21(2):115-137
114. Marie P (2001) Différenciation, fonction et contrôle de l'ostéoblaste. MS Med Sci 17:1252-1259
115. Matsumoto H, Ikoma Y, Sugiura M et al (2004) Identification and quantification of the conjugated metabolites derived from orally administered hesperidin in rat plasma. J Agric Food Chem 52(21):6653-6659
116. McKay DL, Blumberg JB (2002) The role of tea in human health: an update. J Am Coll Nutr 21(1):1-13
117. Mei J, Yeung SS, Kung AW (2001) High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J Clin Endocrinol Metab 86(11):5217-5221
118. Mennen LI, Walker R, Bennetau-Pelissero C et al (2005) Risks and safety of polyphenol consumption. Am J Clin Nutr 81(1 Suppl):326-329
119. Miksicek RJ (1993) Commonly occurring plant flavonoids have estrogenic activity. Mol Pharmacol 44(1):37-43
120. Miyake M, Arai N, Ushio S et al (2003) Promoting effect of kaempferol on the differentiation and mineralization of murine pre-osteoblastic cell line MC3T3-E1. Biosci Biotechnol Biochem 67(6):1199-1205
121. Miyamoto M, Matsushita Y, Kiyokawa A et al (1998) Prenylflavonoids: a new class of non-steroidal phytoestrogen (Part 2). Estrogenic effects of 8-isopentenylnaringenin on bone metabolism. Planta Med 64(6):516-519
122. Mizutani A, Sugiyama I, Kuno E et al (2001) Expression of matrix metalloproteinases during ascorbate-induced differentiation of osteoblastic MC3T3-E1 cells. J Bone Miner Res 16(11):2043-2049
123. Mizutani K, Ikeda K, Kawai Y et al (1998) Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-E1 cells. Biochem Biophys Res Commun 253(3):859-863
124. Morabito N, Crisafulli A, Vergara C et al (2002) Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. J Bone Miner Res 17(10):1904-1912
125. Muhlbauer RC, Lozano A, Palacio S et al (2003a) Common herbs, essential oils, and monoterpenes potently modulate bone metabolism. Bone 32(4):372-380
126. Muhlbauer RC, Lozano A, Reinli A (2002) Onion and a mixture of vegetables, salads, and herbs affect bone resorption in the rat by a mechanism independent of their base excess. J Bone Miner Res 17(7):1230-1236
127. Muhlbauer RC, Lozano A, Reinli A et al (2003b) Various selected vegetables, fruits, mushrooms and red wine residue inhibit bone resorption in rats. J Nutr 133(11):3592-3597
128. Mundy G, Garrett R, Harris S et al (1999) Stimulation of bone formation in vitro and in rodents by statins. Science 286(5446):1946-1949
129. Nakagawa H, Wachi M, Woo JT et al (2002) Fenton reaction is primarily involved in a mechanism of (-)-epigallocatechin-3-gallate to induce osteoclastic cell death. Biochem Biophys Res Commun 292(1):94-101
130. New SA (1999) Bone health: the role of micronutrients. Br Med Bull 55(3):619-633
131. New SA, Millward DJ (2003) Calcium, protein, and fruit and vegetables as dietary determinants of bone health. Am J Clin Nutr 77(5):1340-1341
132. New SA, Robins SP, Campbell MK et al (2000) Dietary influences on bone mass and bone metabolism: further evidence of a positive link between fruit and vegetable consumption and bone health? Am J Clin Nutr 71(1):142-151
133. Nikander E, Metsa-Heikkila M, Ylikorkala O et al (2004) Effects of phytoestrogens on bone turnover in postmenopausal women with a history of breast cancer. J Clin Endocrinol Metab 89(3):1207-1212
134. Notoya M, Tsukamoto Y, Nishimura H et al (2004) Quercetin, a flavonoid, inhibits the proliferation, differentiation, and mineralization of osteoblasts in vitro. Eur J Pharmacol 485(1-3):89-96
135. Okamoto F, Okabe K, Kajiya H (2001) Genistein, a soybean isoflavone, inhibits inward rectifier K(+) channels in rat osteoclasts. Jpn J Physiol 51(4):501-509
136. Omi N, Aoi S, Murata K et al (1994) Evaluation of the effect of soybean milk and soybean milk peptide on bone metabolism in the rat model with ovariectomized osteoporosis. J Nutr Sci Vitaminol (Tokyo) 40(2):201-211
137. Pacifici R (1998) Cytokines, estrogen, and postmenopausal osteoporosis - the second decade. Endocrinology 139(6):2659-2661
138. Pang JL, Ricupero DA, Huang S et al (2006) Differential activity of kaempferol and quercetin in attenuating tumor necrosis factor receptor family signaling in bone cells. Biochem Pharmacol 71(6):818-826
139. Park EK, Kim MS, Lee SH et al (2004) Furosin, an ellagitannin, suppresses RANKL-induced osteoclast differentiation and function through inhibition of MAP kinase activation and actin ring formation. Biochem Biophys Res Commun 325(4):1472-1480
140. Pettifor JM, Prentice A, Cleaton-Jones P (2003) The sletelal system. In: Gibney MJ, Macdonald IA, Roche HM (eds) Nutrition and metabolism. Blackwell Publishing, Oxford, pp 247-283
141. Picherit C, Bennetau-Pelissero C, Chanteranne B et al (2001a) Soybean isoflavones dose-dependently reduce bone turnover but do not reverse established osteopenia in adult ovariectomized rats. J Nutr 131(3):723-728
142. Picherit C, Chanteranne B, Bennetau-Pelissero C et al (2001b) Dose-dependent bone-sparing effects of dietary isoflavones in the ovariectomised rat. Br J Nutr 85(3):307-316
143. Picherit C, Coxam V, Bennetau-Pelissero C et al (2000) Daidzein is more efficient than genistein in preventing ovariectomy-induced bone loss in rats. J Nutr 130(7):1675-1681
144. Picherit C, Horcajada MN, Mathey J et al (2003) Isoflavone consumption does not increase the bone mass in osteopenic obese female zucker rats. Ann Nutr Metab 47(2):70-77
145. Pittenger MF, Mackay AM, Beck SC et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284(5411):143-147
146. Potter SM, Baum JA, Teng H et al (1998) Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 68(6 Suppl):1375S-1379S
147. Power KA, Ward WE, Chen JM et al (2006) Genistein alone and in combination with the mammalian lignans enterolactone and enterodiol induce estrogenic effects on bone and uterus in a postmenopausal breast cancer mouse model. Bone 39(1):117-124
148. Prior RL, Gu LW (2005) Occurrence and biological significance of proanthocyanidins in the American diet. Phytochemistry 66(18):2264-2280
149. Prouillet C, Maziere JC, Maziere C et al (2004) Stimulatory effect of naturally occurring flavonols quercetin and kaempferol on alkaline phosphatase activity in MG-63 human osteoblasts through ERK and estrogen receptor pathway. Biochemical Pharmacology 67(7):1307-1313
150. Puel C, Mardon J, Kati-Coulibaly S et al (2007) Black Lucques olives prevented bone loss caused by ovariectomy and talc granulomatosis in rats. Br J Nutr 97(5):1012-1020
151. Puel C, Mathey J, Agalias A et al (2006) Dose-response study of effect of oleuropein, an olive oil polyphenol, in an ovariectomy/inflammation experimental model of bone loss in the rat. Clin Nutr 25(5):859-868
152. Puel C, Quintin A, Agalias A et al (2004) Olive oil and its main phenolic micronutrient (oleuropein) prevent inflammation-induced bone loss in the ovariectomised rat. Br J Nutr 92(1):119-127
153. Puel C, Quintin A, Mathey J et al (2005) Prevention of bone loss by phloridzin, an apple polyphenol, in ovariectomized rats under inflammation conditions. Calcif Tissue Int 77(5):311-318
154. Rasmussen SE, Frederiksen H, Krogholm KS et al (2005) Dietary proanthocyanidins: occurrence, dietary intake, bioavailability, and protection against cardiovascular disease. Mol Nutr Food Res 49(2):159-174
155. Rassi CM, Lieberherr M, Chaumaz G et al (2002) Down-regulation of osteoclast differentiation by daidzein via caspase 3. J Bone Miner Res 17(4):630-638
156. Ross JA, Kasum CM (2002) Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr 22:19-34
157. Rossouw JE, Anderson GL, Prentice RL et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial. JAMA 288(3):321-333
158. Rucinski M, Ziolkowska A, Hochol A et al (2006) Estradiol and resveratrol stimulating effect on osteocalcin, but not osteonectin and collagen-1alpha gene expression in primary culture of rat calvarial osteoblast-like cells. Int J Mol Med 18(4):565-570
159. Sambrook P, Cooper C (2006) Osteoporosis. Lancet 367(9527):2010-2018
160. Santos-Buelga C, Scalbert A (2000) Proanthocyanidins and tannin-like compounds - nature, occurrence, dietary intake and effects on nutrition and health. J Sci Food Agr 80(7):1094-1117
161. Scalbert A, Manach C, Morand C et al (2005) Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 45(4):287-306
162. Scheiber MD, Liu JH, Subbiah MT et al (2001) Dietary inclusion of whole soy foods results in significant reductions in clinical risk factors for osteoporosis and cardiovascular disease in normal postmenopausal women. Menopause 8(5):384-392
163. Setchell KDR, Brown NM, Lydeking-Olsen E (2002) The clinical importance of the metabolite equol - A clue to the effectiveness of soy and its isoflavones. J Nutr 132(12):3577-3584
164. Somekawa Y, Chiguchi M, Ishibashi T et al (2001) Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women. Obstet Gynecol 97(1):109-115
165. Son YO, Kook SH, Choi KC et al (2006) Quercetin, a bioflavonoid, accelerates TNF-alpha-induced growth inhibition and apoptosis in MC3T3-E1 osteoblastic cells. Eur J Pharmacol 529(1-3):24-32
166. Soung DY, Devareddy L, Khalil DA et al (2006) Soy affects trabecular microarchitecture and favorably alters select bone-specific gene expressions in a male rat model of osteoporosis. Calcif Tissue Int 78(6):385-391
167. Stein GS, Lian JB (1993) Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev 14(4):424-442
168. Strewler GJ (2001) Local and systemic control of the osteoblast. J Clin Investig 107(3):271-272
169. Suda T, Takahashi N, Udagawa N et al (1999) Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20(3):345-357
170. Suda T, Udagawa N, Nakamura I et al (1995) Modulation of osteoclast differentiation by local factors. Bone 17(2 Suppl):87S-91S
171. Sugimoto E, Yamaguchi M (2000a) Anabolic effect of genistein in osteoblastic MC3T3-E1 cells. Int J Mol Med 5(5):515-520
172. Sugimoto E, Yamaguchi M (2000b) Stimulatory effect of Daidzein in osteoblastic MC3T3-E1 cells. Biochem Pharmacol 59(5):471-475
173. Sugiyama M, Kodama T, Konishi K et al (2000) Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells. Biochem Biophys Res Commun 271(3):688-692
174. Suh KS, Koh G, Park CY et al (2003) Soybean isoflavones inhibit tumor necrosis factor-alpha-induced apoptosis and the production of interleukin-6 and prostaglandin E2 in osteoblastic cells. Phytochemistry 63(2):209-215
175. Toda T, Uesugi T, Hirai K et al (1999) New 6-O-acyl isoflavone glycosides from soybeans fermented with Bacillus subtilis (natto). I. 6-O-succinylated isoflavone glycosides and their preventive effects on bone loss in ovariectomized rats fed a calcium-deficient diet. Biol Pharm Bull 22(11):1193-1201
176. Tomas-Barberan FA, Clifford MN (2000) Flavanones, chalcones and dihydrochalcones - nature, occurrence and dietary burden. J Sci Food Agr 80(7):1073-1080
177. Turner RT, Riggs BL, Spelsberg TC (1994) Skeletal effects of estrogen. Endocr Rev 15(3):275-300
178. Uesugi T, Fukui Y, Yamori Y (2002) Beneficial effects of soybean isoflavone supplementation on bone metabolism and serum lipids in postmenopausal Japanese women: a four-week study. J Am Coll Nutr 21(2):97-102
179. Viereck V, Grundker C, Blaschke S et al (2002) Phytoestrogen genistein stimulates the production of osteoprotegerin by human trabecular osteoblasts. J Cell Biochem 84(4):725-735
180. Wang LQ (2002) Mammalian phytoestrogens: enterodiol and enterolactone. J Chromatogr B Analyt Technol Biomed Life Sci 777(1-2):289-309
181. Ward WE, Yuan YV, Cheung AM et al (2001) Exposure to purified lignan from flaxseed (Linum usitatissimum) alters bone development in female rats. Br J Nutr 86(4):499-505
182. Wattel A, Kamel S, Mentaverri R et al (2003) Potent inhibitory effect of naturally occurring flavonoids quercetin and kaempferol on in vitro osteoclastic bone resorption. Biochem Pharmacol 65(1):35-42
183. Wattel A, Kamel S, Prouillet C et al (2004) Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NF kappa B and AP-1. J Cell Biochem 92(2):285-295
184. Weaver CM, Cheong JMK (2005) Soy isoflavones and bone health: The
185. Westendorf JJ, Kahler RA, Schroeder TM (2004) Wnt signaling in osteoblasts and bone diseases. Gene 341:19-39
186. Williams JP, Jordan SE, Barnes S et al (1998) Tyrosine kinase inhibitor effects on avian osteoclastic acid transport. Am J Clin Nutr 68(6 Suppl):1369S-1374S
187. Williamson G, Manach C (2005) Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 81(1):243S-255S
188. Wong RWK, Rabie ABM (2006a) Effect of naringin collagen graft on bone formation. Biomaterials 27(9):1824-1831
189. Wong RWK, Rabie ABM (2006b) Effect of naringin on bone cells. J Orthop Res 24(11):2045-2050
190. Woo JT, Nakagawa H, Notoya M et al (2004) Quercetin suppresses bone resorption by inhibiting the differentiation and activation of osteoclasts. Biol Pharm Bull 27(4):504-509
191. Wu J, Wang XX, Chiba H et al (2003) Combined intervention of exercise and genistein prevented androgen deficiency-induced bone loss in mice. J Appl Physiol 94(1):335-342
192. Yamaguchi M, Gao YH (1997) Anabolic effect of genistein on bone metabolism in the femoral-metaphyseal tissues of elderly rats is inhibited by the anti-estrogen tamoxifen. Res Exp Med (Berl) 197(2):101-107
193. Yamaguchi M, Gao YH (1998a) Anabolic effect of genistein and genistin on bone metabolism in the femoral-metaphyseal tissues of elderly rats: the genistein effect is enhanced by zinc. Mol Cell Biochem 178(1-2):377-382
194. Yamaguchi M, Gao YH (1998b) Inhibitory effect of genistein on bone resorption in tissue culture. Biochem Pharmacol 55(1):71-76
195. Yamaguchi M, Sugimoto E (2000) Stimulatory effect of genistein and daidzein on protein synthesis in osteoblastic MC3T3-E1 cells: activation of aminoacyl-tRNA synthetase. Mol Cell Biochem 214(1-2):97-102
196. Yoshida H, Teramoto T, Ikeda K et al (2001) Glycitein effect on suppressing the proliferation and stimulating the differentiation of osteoblastic MC3T3-E1 cells. Biosci Biotechnol Biochem 65(5):1211-1213
197. Yun JH, Pang EK, Kim CS et al (2004) Inhibitory effects of green tea polyphenol (-)-epigallocatechin gallate on the expression of matrix metalloproteinase-9 and on the formation of osteoclasts. J Periodontal Res 39(5):300-307
198. Zhang XL, Shu XO, Li HL et al (2005) Prospective cohort study of soy food consumption and risk of bone fracture among postmenopausal women. Arch Intern Med 165(16):1890-1895